Literature DB >> 19271773

Crystal structures of brain group-VIII phospholipase A2 in nonaged complexes with the organophosphorus nerve agents soman and sarin.

Todd M Epstein1, Uttamkumar Samanta, Stephen D Kirby, Douglas M Cerasoli, Brian J Bahnson.   

Abstract

Insecticide and nerve agent organophosphorus (OP) compounds are potent inhibitors of the serine hydrolase superfamily of enzymes. Nerve agents, such as sarin, soman, tabun, and VX exert their toxicity by inhibiting human acetycholinesterase at nerve synapses. Following the initial phosphonylation of the active site serine, the enzyme may reactivate spontaneously or through reaction with an appropriate nucleophilic oxime. Alternatively, the enzyme-nerve agent complex can undergo a secondary process, called "aging", which dealkylates the nerve agent adduct and results in a product that is highly resistant to reactivation by any known means. Here we report the structures of paraoxon, soman, and sarin complexes of group-VIII phospholipase A2 from bovine brain. In each case, the crystal structures indicate a nonaged adduct; a stereoselective preference for binding of the P(S)C(S) isomer of soman and the P(S) isomer of sarin was also noted. The stability of the nonaged complexes was corroborated by trypsin digest and electrospray ionization mass spectrometry, which indicates nonaged complexes are formed with diisopropylfluorophosphate, soman, and sarin. The P(S) stereoselectivity for reaction with sarin was confirmed by reaction of racemic sarin, followed by gas chromatography/mass spectrometry using a chiral column to separate and quantitate each stereoisomer. The P(S) stereoisomers of soman and sarin are known to be the more toxic stereoisomers, as they react preferentially to inhibit human acetylcholinesterase. The results obtained for nonaged complexes of group-VIII phospholipase A2 are compared to those obtained for other serine hydrolases and discussed to partly explain determinants of OP aging. Furthermore, structural insights can now be exploited to engineer variant versions of this enzyme with enhanced nerve agent binding and hydrolysis functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19271773      PMCID: PMC2671691          DOI: 10.1021/bi8023527

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  Structure of diisopropyl fluorophosphate-inhibited factor D.

Authors:  L B Cole; N Chu; J M Kilpatrick; J E Volanakis; S V Narayana; Y S Babu
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-03-01

2.  Direct determination of the chemical composition of acetylcholinesterase phosphonylation products utilizing electrospray-ionization mass spectrometry.

Authors:  R Barak; A Ordentlich; D Barak; M Fischer; H P Benschop; L P De Jong; Y Segall; B Velan; A Shafferman
Journal:  FEBS Lett       Date:  1997-05-05       Impact factor: 4.124

3.  Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase.

Authors:  H Manya; J Aoki; H Kato; J Ishii; S Hino; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

4.  Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun.

Authors:  Christopher D Fleming; Carol C Edwards; Stephen D Kirby; Donald M Maxwell; Philip M Potter; Douglas M Cerasoli; Matthew R Redinbo
Journal:  Biochemistry       Date:  2007-04-04       Impact factor: 3.162

5.  Ageing and dealkylation of Soman (pinacolylmethylphosphonofluoridate)-inactivated eel cholinesterase.

Authors:  H O Michel; B E Hackley; L Berkowitz; G List; E B Hackley; W Gillilan; M Pankau
Journal:  Arch Biochem Biophys       Date:  1967-07       Impact factor: 4.013

6.  Aging of di-isopropyl-phosphorylated human butyrylcholinesterase.

Authors:  P Masson; P L Fortier; C Albaret; M T Froment; C F Bartels; O Lockridge
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

7.  Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers.

Authors:  A Ordentlich; D Barak; C Kronman; H P Benschop; L P De Jong; N Ariel; R Barak; Y Segall; B Velan; A Shafferman
Journal:  Biochemistry       Date:  1999-03-09       Impact factor: 3.162

8.  Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis.

Authors:  Uttamkumar Samanta; Brian J Bahnson
Journal:  J Biol Chem       Date:  2008-09-10       Impact factor: 5.157

9.  P NMR and mass spectrometry of atropinesterase and some serine proteases phosphorylated with a transition-state analogue.

Authors:  A C van der Drift; H C Beck; W H Dekker; A G Hulst; E R Wils
Journal:  Biochemistry       Date:  1985-11-19       Impact factor: 3.162

10.  Dealkylation and loss of capacity for reactivation of cholinesterase inhibited by sarin.

Authors:  L W Harris; J H Fleisher; J Clark; W J Cliff
Journal:  Science       Date:  1966-10-21       Impact factor: 47.728

View more
  8 in total

1.  Synthesis and kinetic analysis of some phosphonate analogs of cyclophostin as inhibitors of human acetylcholinesterase.

Authors:  Supratik Dutta; Raj K Malla; Saibal Bandyopadhyay; Christopher D Spilling; Cynthia M Dupureur
Journal:  Bioorg Med Chem       Date:  2010-02-04       Impact factor: 3.641

2.  Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo.

Authors:  Denis G Ilyushin; Ivan V Smirnov; Alexey A Belogurov; Igor A Dyachenko; Tatiana Iu Zharmukhamedova; Tatjana I Novozhilova; Eugene A Bychikhin; Marina V Serebryakova; Oleg N Kharybin; Arkadii N Murashev; Konstantin A Anikienko; Eugene N Nikolaev; Natalia A Ponomarenko; Dmitry D Genkin; G Michael Blackburn; Patrick Masson; Alexander G Gabibov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

Review 3.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

4.  Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin.

Authors:  Andrew C Hemmert; Tamara C Otto; Monika Wierdl; Carol C Edwards; Christopher D Fleming; Mary MacDonald; John R Cashman; Philip M Potter; Douglas M Cerasoli; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2010-01-05       Impact factor: 4.436

5.  Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes.

Authors:  Uttamkumar Samanta; Stephen D Kirby; Prabhavathi Srinivasan; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochem Pharmacol       Date:  2009-04-24       Impact factor: 5.858

6.  A rationally designed mutant of plasma platelet-activating factor acetylhydrolase hydrolyzes the organophosphorus nerve agent soman.

Authors:  Stephen D Kirby; Joseph Norris; Richard Sweeney; Brian J Bahnson; Douglas M Cerasoli
Journal:  Biochim Biophys Acta       Date:  2015-09-03

7.  The structure of Phocaeicola vulgatus sialic acid acetylesterase.

Authors:  Hannah Scott; Gideon J Davies; Zachary Armstrong
Journal:  Acta Crystallogr D Struct Biol       Date:  2022-04-26       Impact factor: 5.699

8.  Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Authors:  Rudy J Richardson; John K Fink; Paul Glynn; Robert B Hufnagel; Galina F Makhaeva; Sanjeeva J Wijeyesakere
Journal:  Adv Neurotoxicol       Date:  2020-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.